Biocryst Pharmaceuticals Inc (BCRX)
R&D Expense Growth
-13.84%
Quarterly · Period ending:
BCRX R&D Expense Growth
Latest reported-13.84%period ending
Latest reported-13.84%period ending
BCRX Quarterly R&D Growth (QoQ) (0.00% → -13.84%)
Latest values, visible window
High-resolution chart · PNG
BCRX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 7.2727% | |
| -13.1882% | |
| 43.0006% | |
| -24.5744% | |
| 39.5387% | |
| 7.5767% | |
| -5.2632% | |
| 5.5556% | |
| -18.1818% | |
| 37.5% | |
| -33.3333% | |
| -7.6923% | |
| -3.7037% | |
| -3.5714% | |
| 16.6667% | |
| -4% | |
| -13.7931% | |
| 0% | |
| -100% | |
| 15.7895% | |
| 26.6667% | |
| 0% | |
| -100% | |
| 30.7692% | |
| -48% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |